Cattle Press Releases

BQA Free Certification Period Announced

During the 2016 Annual Cattle Industry Convention, Boehringer Ingelheim Vetmedica, Inc. (BIVI), announced a Beef Quality Assurance (BQA) free-certification period — from now through April 15. Beef and dairy producers can take advantage of free BQA certification online courtesy of BIVI and the BQA program, which is funded in part by the beef checkoff. Register today and complete your certification at your own convenience.

Dairies Can Save Thousands with Strategic Mastitis Treatment

Reducing mastitis treatment costs by tens of thousands of dollars is possible, according to a new study from Cornell University. This study identifies a more calculated approach to mastitis treatments that reduces the overall amount of antibiotics needed. Not only does this new approach provide excellent cure rates, it is more cost-effective for dairy producers.

“The results should change the way dairies look at mastitis treatment,” continues Dr. Tikosfky. “There were no statistically significant differences between the two groups in clinical cure, next-test-day milk production, somatic cell counts or risk of culling. But the days out of the bulk tank were much higher for the blanket therapy group, at almost nine days versus seven days for the culture group.”

The study concludes that the additional cost of unnecessary antibiotics, combined with the amount of milk discarded, can cost dairy producers more than $32,000 per 1,000 cows.

Earn Free Beef Quality Assurance Certification This Fall

From now through Nov. 20, producers and those affiliated with the cattle industry can take advantage of free Beef Quality Assurance (BQA) online certification at This opportunity is possible through a partnership between Boehringer Ingelheim Vetmedica, Inc. (BIVI) and the check-off funded BQA program.

Help Support Young Veterinary Careers

For the second year, in support of its Prevention Works philosophy, Boehringer Ingelheim Vetmedica, Inc. (BIVI) is offering Future Service Scholarships to support future cattle veterinarians graduating from the Iowa State University (ISU) College of Veterinary Medicine.

Boehringer Ingelheim Vetmedica, Inc. Announces New Leadership Positions

In efforts to deepen its expertise as a leader in equine and cattle health, Boehringer Ingelheim Vetmedica, Inc. (BIVI) announces Dr. Scott King as the new director of the U.S. Cattle Marketing team, and Amanda McAvoy as senior associate director of the U.S. Equine Marketing team.

Boehringer Ingelheim Vetmedica, Inc. Helps New Diagnostic Center Break Ground

The University of Nebraska-Lincoln (UNL) recently broke ground on its new Veterinary Diagnostic Center. Boehringer Ingelheim Vetmedica, Inc. (BIVI) contributed support for the state-of-the-art facility that will provide improved service to livestock producers and veterinarians throughout the region and the country. It is expected to open by the end of 2017.

The University of Nebraska-Lincoln officially broke ground on its new Veterinary Diagnostic Center at a ceremony on April 29, 2015. Boehringer Ingelheim Vetmedica, Inc. (BIVI) contributed support for the $44.7 million state-of-the-art facility that will provide improved service to livestock producers and veterinarians throughout the region and the country.

From left to right:
Mike Foley, Lt. Governor, Nebraska
Hank Bounds, president, University of Nebraska

Nebraska BIVI sales representatives Dan Wolfe of Raymond and Ben Siegfried of McCook visit with Nebraska Department of Agriculture Director Greg Ibach. The Department of Agriculture oversees the state veterinarian's office, which is responsible for monitoring the health of livestock herds. Ibach said the center is an invaluable partner to producers in the state.

New option for vaccinating against pneumonia caused by M. haemolytica

Pneumonia has always been a concern for dairy producers and Mannheimia haemolytica (M. haemolytica, formerly called Pasteurella haemolytica) is the most common cause of bacterial pneumonia in cattle.1 Exposure to respiratory viruses, coupled with reduced immunity caused by overcrowding, new herd additions, transportation, ventilation insufficiencies and sudden weather changes are factors that increase the risk of this type of pneumonia.

Pyramid® 5 + Presponse® SQ Approved for Extended BVD 1b Protection

ST. JOSPEH, Mo. (Feb. 19, 2015) —Pyramid® 5 + Presponse® SQ from Boehringer Ingelheim Vetmedica, Inc. (BIVI) recently received a new label claim for protection against respiratory disease caused by bovine viral diarrhea (BVD) Type 1b for at least 217 days. BVD Type 1b is the most common subtype of BVD found in persistently infected (PI) calves. This new claim reinforces the elite BVD protection offered by BIVI's modified-live virus (MLV) vaccine portfolio.